Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
17.89
+0.07 (0.39%)
At close: Nov 28, 2025, 1:00 PM EST
17.83
-0.06 (-0.34%)
After-hours: Nov 28, 2025, 4:26 PM EST
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $13.8 billion as of November 28, 2025. Its market cap has decreased by -9.89% in one year.
Market Cap
13.80B
Enterprise Value
13.56B
1-Year Change
-9.89%
Ranking
Category
Stock Price
$17.89
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $13.80B, an increase of 11,493.18%. That is a compound annual growth rate of 55.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 13.32B | 1.20% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |